Q: Your answer to Jo-Anne's question this morning about Reliq's contract announcement seems fair (another 'good' contract but previous one's haven't translated into much revenue).
However, there was a 2nd simultaneous press release regarding a 'Non-Brokered Private Placement' in which they announce their on-boarding partners (one of them being the new contract announcement this morning) have invested in the company. At first a raise at the low share price seems negative but when your clients invest in your company, you would think they'd be motivated to onboard patients to increase revenue. Does this drastically change the risk/reward for an investor in RHT?
However, there was a 2nd simultaneous press release regarding a 'Non-Brokered Private Placement' in which they announce their on-boarding partners (one of them being the new contract announcement this morning) have invested in the company. At first a raise at the low share price seems negative but when your clients invest in your company, you would think they'd be motivated to onboard patients to increase revenue. Does this drastically change the risk/reward for an investor in RHT?